Copyright (c) 2009 Yahoo! Inc. All rights reserved. http://news.yahoo.com/i/1190 business Business - Pharmaceutical en-us Fri, 06 Nov 2009 16:21:13 GMT 5 142 18 http://news.yahoo.com/i/1190 http://l.yimg.com/a/i/us/nws/th/main_142b.gif http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091106/ap_on_bi_ge/us_earns_halozyme ap/20091106/us_earns_halozyme AP business Fri, 06 Nov 2009 16:21:13 GMT AP - Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091106/ap_on_bi_ge/us_earns_threshold_pharmaceuticals ap/20091106/us_earns_threshold_pharmaceuticals AP business Fri, 06 Nov 2009 15:43:53 GMT AP - Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091106/ap_on_re_us/us_massachusetts_terror_charge ap/20091106/us_massachusetts_terror_charge AP us Fri, 06 Nov 2009 03:01:16 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091106/ap_on_re_us/us_massachusetts_terror_charge"><img src="http://d.yimg.com/a/p/ap/20091022/capt.b137039746904bb084197beae3f7b3b8.massachusetts_terror_charge_bx101.jpg?x=130&y=94&q=85&sig=em.Dzgk1RAAjO2ZRJ.XfPg--" align="left" height="94" width="130" alt="In this Feb. 11, 2009 image rendered from video and provided by WHDH-TV in Boston, Tarek Mehanna is seen outside the federal court in Boston. Federal authorities in Boston said Wednesday, Oct. 21, 2009, that Mehanna has been charged with conspiring with others on terror attacks against shoppers in U.S. malls and against U.S. military in Iraq. (AP Photo/WHDH-TV)" border="0" /></a>AP - A pharmacy college graduate was indicted Thursday on new charges in an alleged terror plot to kill two prominent U.S. politicians and shoot people at American shopping malls.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091106/ap_on_re_us/us_massachusetts_terror_charge"><img src="http://d.yimg.com/a/p/ap/20091022/capt.b137039746904bb084197beae3f7b3b8.massachusetts_terror_charge_bx101.jpg?x=130&y=94&q=85&sig=em.Dzgk1RAAjO2ZRJ.XfPg--" align="left" height="94" width="130" alt="photo" title="In this Feb. 11, 2009 image rendered from video and provided by WHDH-TV in Boston, Tarek Mehanna is seen outside the federal court in Boston. Federal authorities in Boston said Wednesday, Oct. 21, 2009, that Mehanna has been charged with conspiring with others on terror attacks against shoppers in U.S. malls and against U.S. military in Iraq. (AP Photo/WHDH-TV)" border="0"/></a></p><br clear="all"/> (AP) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091105/ap_on_bi_ge/us_on_the_call_cigna ap/20091105/us_on_the_call_cigna AP business Thu, 05 Nov 2009 21:51:47 GMT AP - Health insurer WellPoint Inc. announced plans last spring to sell its pharmacy benefits management business to Express Scripts Inc. for about $4.68 billion. Analysts have wondered whether other managed care companies would consider a similar sale. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091105/ap_on_bi_ge/us_earns_cvs_caremark ap/20091105/us_earns_cvs_caremark AP business Thu, 05 Nov 2009 21:49:24 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091105/ap_on_bi_ge/us_earns_cvs_caremark"><img src="http://d.yimg.com/a/p/ap/20091105/capt.5f7ea3b5e8da46e1a1d7edb83195c89b.earns_cvs_caremark_risr201.jpg?x=130&y=89&q=85&sig=.Nn8psh6z5MmT0K_j8rUUw--" align="left" height="89" width="130" alt="In this Nov. 3, 2009 photo, a CVS pharmacy sign is seen opposite the interior of one of the CVS locations, in Providence, R.I. CVS Caremark Corp. said Thursday, Nov. 5, 2009, its third-quarter profit jumped 39 percent on a boost from pharmacy benefits services and drugstore sales. (AP Photo/Steven Senne)" border="0" /></a>AP - CVS Caremark disclosed more multibillion dollar contract losses in its pharmacy benefits management business and said the head of the unit will depart.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091105/ap_on_bi_ge/us_earns_cvs_caremark"><img src="http://d.yimg.com/a/p/ap/20091105/capt.5f7ea3b5e8da46e1a1d7edb83195c89b.earns_cvs_caremark_risr201.jpg?x=130&y=89&q=85&sig=.Nn8psh6z5MmT0K_j8rUUw--" align="left" height="89" width="130" alt="photo" title="In this Nov. 3, 2009 photo, a CVS pharmacy sign is seen opposite the interior of one of the CVS locations, in Providence, R.I. CVS Caremark Corp. said Thursday, Nov. 5, 2009, its third-quarter profit jumped 39 percent on a boost from pharmacy benefits services and drugstore sales. (AP Photo/Steven Senne)" border="0"/></a></p><br clear="all"/> (AP) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091105/ap_on_bi_ge/us_earns_king_pharmaceuticals ap/20091105/us_earns_king_pharmaceuticals AP business Thu, 05 Nov 2009 15:43:44 GMT AP - Drug developer King Pharmaceuticals said Thursday its third-quarter profit was cut in half by charges for related to its $1.6 billion buyout of rival Alpharma Inc. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091105/ap_on_bi_ge/us_biocryst_pharmaceuticals_peramivir ap/20091105/us_biocryst_pharmaceuticals_peramivir AP business Thu, 05 Nov 2009 13:55:41 GMT AP - BioCryst Pharmaceuticals Inc. said Thursday it will receive $22.5 million as part of a new contract with the Department of Health and Human Services over the intravenous flu treatment peramivir. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091104/ap_on_bi_ge/us_earns_medicis ap/20091104/us_earns_medicis AP business Wed, 04 Nov 2009 23:21:12 GMT AP - Medicis Pharmaceutical Corp. posted a third-quarter profit on Wednesday, as sales of its skin products surged, and a research and development charge came off the books. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091104/ap_on_bi_ge/us_biocryst_pharma_peramivir_filing ap/20091104/us_biocryst_pharma_peramivir_filing AP business Wed, 04 Nov 2009 18:49:15 GMT AP - BioCryst Pharmaceuticals Inc. said Wednesday its partner Shionogi & Co. filed for approval to market BioCryst's IV flu drug peramivir in Japan. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091104/ap_on_bi_ge/us_earns_affymax ap/20091104/us_earns_affymax AP business Wed, 04 Nov 2009 15:18:03 GMT AP - Biotechnology company Affymax Inc. said Wednesday its third-quarter loss narrowed on a boost in payments from its partner Takeda Pharmaceutical on the anemia drug candidate Hematide. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091104/ap_on_bi_ge/us_earns_watson_pharmaceuticals ap/20091104/us_earns_watson_pharmaceuticals AP business Wed, 04 Nov 2009 14:50:30 GMT AP - Drug developer Watson Pharmaceuticals Inc. said Wednesday its profit fell 11 percent in the third quarter as higher taxes and charges offset a revenue boost. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/ts_alt_afp/uscompanymergerpharmamerckscheringplough afp/20091103/uscompanymergerpharmamerckscheringplough AFP us Tue, 03 Nov 2009 21:55:27 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/ts_alt_afp/uscompanymergerpharmamerckscheringplough"><img src="http://d.yimg.com/a/p/afp/20091103/capt.photo_1257285297405-1-0.jpg?x=130&y=81&q=85&sig=GbLJPKyws4lhkLnYuNSLKA--" align="left" height="81" width="130" alt="A car enters the employee entrace at the headquarters for drug maker Merck in Kenilworth, New Jersey. US pharmaceutical giant Merck & Co. finalized its acquisition of rival Schering-Plough on Tuesday, a 41-billion-dollar deal creating the number two firm in the sector.(AFP/Getty Images/File/Chris Hondros)" border="0" /></a>AFP - US pharmaceutical giant Merck & Co. finalized its acquisition of rival Schering-Plough on Tuesday, a 41-billion-dollar deal creating the number two firm in the sector.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/ts_alt_afp/uscompanymergerpharmamerckscheringplough"><img src="http://d.yimg.com/a/p/afp/20091103/capt.photo_1257285297405-1-0.jpg?x=130&y=81&q=85&sig=GbLJPKyws4lhkLnYuNSLKA--" align="left" height="81" width="130" alt="photo" title="A car enters the employee entrace at the headquarters for drug maker Merck in Kenilworth, New Jersey. US pharmaceutical giant Merck & Co. finalized its acquisition of rival Schering-Plough on Tuesday, a 41-billion-dollar deal creating the number two firm in the sector.(AFP/Getty Images/File/Chris Hondros)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091103/ap_on_bi_ge/us_earns_medco_health_solutions ap/20091103/us_earns_medco_health_solutions AP business Tue, 03 Nov 2009 18:29:37 GMT AP - Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, said Tuesday its profit rose 13.5 percent as the company gained new clients and benefited from price inflation of brand-name drugs. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/ts_alt_afp/healthfluuswomenchildrenvaccine afp/20091103/healthfluuswomenchildrenvaccine AFP us Tue, 03 Nov 2009 16:35:22 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/ts_alt_afp/healthfluuswomenchildrenvaccine"><img src="http://d.yimg.com/a/p/afp/20091103/capt.photo_1257262213662-1-0.jpg?x=97&y=130&q=85&sig=h4BJn0mAQPGE5UMl5JPaEg--" align="left" height="130" width="97" alt="A nurse gives a shot of the H1N1 vaccine to Mandi Russell, who is seven and a half months pregnant, at the Utah County Health Department in October 2009 in Provo, Utah. A single dose of swine flu vaccine produces a robust immune response in pregnant women, one of the groups at higher risk of dying from (A)H1N1 influenza, initial results from US clinical trials have shown.(AFP/Getty Images/File/George Frey)" border="0" /></a>AFP - A single dose of swine flu vaccine produces a robust immune response in pregnant women, one of the groups at high risk of dying from (A)H1N1 influenza, but young children need two shots, US clinical trials have shown.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/ts_alt_afp/healthfluuswomenchildrenvaccine"><img src="http://d.yimg.com/a/p/afp/20091103/capt.photo_1257262213662-1-0.jpg?x=97&y=130&q=85&sig=h4BJn0mAQPGE5UMl5JPaEg--" align="left" height="130" width="97" alt="photo" title="A nurse gives a shot of the H1N1 vaccine to Mandi Russell, who is seven and a half months pregnant, at the Utah County Health Department in October 2009 in Provo, Utah. A single dose of swine flu vaccine produces a robust immune response in pregnant women, one of the groups at higher risk of dying from (A)H1N1 influenza, initial results from US clinical trials have shown.(AFP/Getty Images/File/George Frey)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/nm/20091103/bs_nm/us_johnsonandjohnson nm/20091103/us_johnsonandjohnson Reuters business Tue, 03 Nov 2009 19:06:54 GMT Reuters - Johnson & Johnson plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said on Tuesday. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/bs_afp/switzerlandchinapharmahealthresearchcompanynovartis afp/20091103/switzerlandchinapharmahealthresearchcompanynovartis AFP business Tue, 03 Nov 2009 10:13:14 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/bs_afp/switzerlandchinapharmahealthresearchcompanynovartis"><img src="http://d.yimg.com/a/p/afp/20091103/capt.photo_1257243141078-1-0.jpg?x=130&y=86&q=85&sig=D5FmSiafQYBxOF5MHffGHQ--" align="left" height="86" width="130" alt="Swiss pharmaceuticals giant Novartis headquarters in Basel. Swiss pharmaceutical group Novartis said that it would invest 1.0 billion dollars (680 million euros) in research and development in China to latch on to growing demand for health care.(AFP/File/Sebastien Bozon)" border="0" /></a>AFP - Swiss pharmaceutical group Novartis said Tuesday that it would invest 1.0 billion dollars (680 million euros) in research and development in China to latch on to growing demand for health care.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/afp/20091103/bs_afp/switzerlandchinapharmahealthresearchcompanynovartis"><img src="http://d.yimg.com/a/p/afp/20091103/capt.photo_1257243141078-1-0.jpg?x=130&y=86&q=85&sig=D5FmSiafQYBxOF5MHffGHQ--" align="left" height="86" width="130" alt="photo" title="Swiss pharmaceuticals giant Novartis headquarters in Basel. Swiss pharmaceutical group Novartis said that it would invest 1.0 billion dollars (680 million euros) in research and development in China to latch on to growing demand for health care.(AFP/File/Sebastien Bozon)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091103/ap_on_bi_ge/us_prempro_trial ap/20091103/us_prempro_trial AP business Tue, 03 Nov 2009 00:21:38 GMT AP - Wyeth Pharmaceuticals will get a new trial to determine if the drugmaker should pay punitive damages to a woman who got breast cancer after taking hormone replacement therapy, a federal appeals court ruled Monday. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091102/ap_on_bi_ge/us_amylin_takeda_contract ap/20091102/us_amylin_takeda_contract AP business Mon, 02 Nov 2009 22:30:36 GMT AP - Amylin Pharmaceuticals Inc. says it could potentially receive more than $1 billion from a partnership with Japan's Takeda Pharmaceutical Co. on potential weight-loss treatments. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091102/ap_on_bi_ge/us_medco_health_earnings_preview ap/20091102/us_medco_health_earnings_preview AP business Mon, 02 Nov 2009 17:20:20 GMT AP - Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, is scheduled to report its third-quarter results Tuesday morning. The following is a summary of key developments and analyst commentary for the period. http://us.rd.yahoo.com/dailynews/rss/pharmaceutical/*http://news.yahoo.com/s/ap/20091102/ap_on_bi_ge/us_earns_valeant_pharmaceuticals ap/20091102/us_earns_valeant_pharmaceuticals AP business Mon, 02 Nov 2009 15:47:31 GMT AP - Valeant Pharmaceuticals International said Monday its third-quarter net income plunged, a year after selling businesses in Europe, Africa, and the Middle East, but adjusted profit topped Wall Street expectations.